Literature DB >> 15949671

Analysis of PIK3C3 promoter variant in African-Americans with schizophrenia.

Takuya Saito, Maryam Rafael Aghalar, Herbert M Lachman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15949671     DOI： 10.1016/j.schres.2005.01.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  10 in total

Review 1.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

2.  No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.

Authors:  Jie Li; Xue Li; Emily Liu; Paul Copeland; Oliver Freudenreich; Donald C Goff; David C Henderson; Xueqin Song; Xiaoduo Fan
Journal:  Schizophr Res       Date:  2013-02-21       Impact factor: 4.939

3.  Establishment of mouse line showing inducible priapism-like phenotypes.

Authors:  Daiki Hashimoto; Kota Fujimoto; Shin Morioka; Shinya Ayabe; Tomoya Kataoka; Ryutaro Fukumura; Yuko Ueda; Mizuki Kajimoto; Taiju Hyuga; Kentaro Suzuki; Isao Hara; Shinichi Asamura; Shigeharu Wakana; Atsushi Yoshiki; Yoichi Gondo; Masaru Tamura; Takehiko Sasaki; Gen Yamada
Journal:  Reprod Med Biol       Date:  2022-06-20

Review 4.  Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention.

Authors:  Natasha M Setiabakti; Pia Larsson; Justin R Hamilton
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

5.  No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  Xiaoduo Fan; Emily Liu; Oliver Freudenreich; Paul Copeland; Douglas Hayden; Musie Ghebremichael; Bruce Cohen; Dost Ongur; Donald C Goff; David C Henderson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

6.  Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Authors:  Silvia N Kariuki; Beverly S Franek; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Andrew D Skol; Timothy B Niewold
Journal:  J Biomed Biotechnol       Date:  2010-07-04

7.  Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism.

Authors:  Anthony Carrard; Annick Salzmann; Nader Perroud; Jérémie Gafner; Alain Malafosse; Félicien Karege
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

Review 8.  Endosomal phosphoinositides and human diseases.

Authors:  Anne-Sophie Nicot; Jocelyn Laporte
Journal:  Traffic       Date:  2008-04-21       Impact factor: 6.215

9.  Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia.

Authors:  Junya Matsumoto; Hiroki Nakanishi; Yasuto Kunii; Yuki Sugiura; Dai Yuki; Akira Wada; Mizuki Hino; Shin-Ichi Niwa; Takeshi Kondo; Michihiko Waki; Takahiro Hayasaka; Noritaka Masaki; Hiroyasu Akatsu; Yoshio Hashizume; Sakon Yamamoto; Shinji Sato; Takehiko Sasaki; Mitsutoshi Setou; Hirooki Yabe
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

10.  Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders.

Authors:  Xueming Yao; Joseph T Glessner; Junyi Li; Xiaohui Qi; Xiaoyuan Hou; Chonggui Zhu; Xiaoge Li; Michael E March; Liu Yang; Frank D Mentch; Heather S Hain; Xinyi Meng; Qianghua Xia; Hakon Hakonarson; Jin Li
Journal:  Transl Psychiatry       Date:  2021-01-21       Impact factor: 6.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.